These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10971502)

  • 1. Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C.
    Downs AM; Dunnill MG
    Clin Exp Dermatol; 2000 Jun; 25(4):351-2. PubMed ID: 10971502
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
    Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C.
    Taylor C; Burns DA; Wiselka MJ
    Postgrad Med J; 2000 Jun; 76(896):365-7. PubMed ID: 10824054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of chronic hepatitis C and response to interferon therapy in older patients.
    Hervé S; Savoye G; Riachi G; Capet C; Goria O; Lerebours E; Colin R
    Age Ageing; 2001 Jul; 30(4):355-6. PubMed ID: 11509317
    [No Abstract]   [Full Text] [Related]  

  • 5. Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C.
    Kartal ED; Colak H; Ozgunes I; Usluer G
    Chemotherapy; 2005 May; 51(2-3):167-9. PubMed ID: 15886478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained virological response after a short course of treatment with interferon and ribavirin in two chronic hepatitis C patients.
    Nousbaum JB; Cadranel JF; Savary O; Legrand MC; Dumouchel P; Gouérou H
    J Hepatol; 2003 Oct; 39(4):655-6. PubMed ID: 12971981
    [No Abstract]   [Full Text] [Related]  

  • 7. Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C.
    Wu MC; Lee JY
    Australas J Dermatol; 2012 Nov; 53(4):e69-72. PubMed ID: 23157789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea.
    Schalm SW
    Gut; 1998 Nov; 43(5):602. PubMed ID: 9824337
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C.
    Bruchfeld A; Ståhle L; Andersson J; Schvarcz R
    Nephrol Dial Transplant; 2001 Aug; 16(8):1729. PubMed ID: 11477195
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of hepatic fibrosis and cirrhosis in patients with chronic hepatitis C treated with interferon-based therapy.
    Metwally MA; Zein CO; Zein NN
    Gastroenterology; 2003 May; 124(5):1561. PubMed ID: 12760398
    [No Abstract]   [Full Text] [Related]  

  • 11. LKM1 antibody and interferon therapy in children with chronic hepatitis C.
    Iorio R; Giannattasio A; Vespere G; Vegnente A
    J Hepatol; 2001 Nov; 35(5):685-7. PubMed ID: 11690721
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
    Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
    Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.
    Beckebaum S; Cicinnati VR; Karliova M; Dirsch O; Erim Y; Frilling A; Malago M; Broelsch CE; Treichel U; Gerken G
    Transplant Proc; 2003 Sep; 35(6):2080-1. PubMed ID: 14529846
    [No Abstract]   [Full Text] [Related]  

  • 14. Difficulties in conducting large-scale studies on rare diseases: the case for pediatric hepatitis C infection.
    Süoglu OD
    J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):235. PubMed ID: 12187309
    [No Abstract]   [Full Text] [Related]  

  • 15. New interferon alfa formulation licensed for treatment of hepatitis C.
    Thompson CA
    Am J Health Syst Pharm; 2001 Mar; 58(6):452. PubMed ID: 11286138
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon therapy in patients with chronic hepatitis C and schistosomiasis.
    Kamal SM; Madwar MA; Peters T; Fawzy R; Rasenack J
    J Hepatol; 2000 Jan; 32(1):172-4. PubMed ID: 10673085
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C.
    Imafuku S; Tashiro A; Furue M
    Br J Dermatol; 2007 Jun; 156(6):1367-9. PubMed ID: 17441954
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune thyroiditis and delayed onset psoriasis in association with combination therapy for chronic hepatitis C infection.
    Chong VH
    Singapore Med J; 2011 Feb; 52(2):e20-2. PubMed ID: 21373724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C.
    Eberlein-König B; Hein R; Abeck D; Engst R; Ring J
    Br J Dermatol; 1999 Feb; 140(2):370-2. PubMed ID: 10233247
    [No Abstract]   [Full Text] [Related]  

  • 20. Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following PEG-interferon and ribavirin treatment.
    Aladag M; Camci C; Huang Y; Wright H; Rizvi S; Gurakar A; Stokes K; Sebastian A
    J Clin Gastroenterol; 2005; 39(10):923-4. PubMed ID: 16208125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.